Medibank was worried that a negative backlash over changes it made to out-of-pocket expenses for its policies represented a "high risk" to its $5.7 billion ASX float in late 2014, a court has heard.
The Australian Competition and Consumer Commission claims Medibank, which listed on the ASX in 2014, misled consumers by not adequately informing them of changes to out-of-pocket expenses for diagnostic services in private hospitals.
Loading...
Lucille Keen writes on News specialising in Politics, Policy, Industrial Relations. Based in our Melbourne newsroom, Lucille has over six years experience as journalist. Connect with Lucille on Twitter.
